Open AccessUse of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy
Author(s) -
Conti Sergio,
Bonomo Vito,
Taormina Antonio,
Giordano Umberto,
Sgarito Giuseppe
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2089
Subject(s) - medicine , implantable cardioverter defibrillator , cardiology , catheter ablation , sudden cardiac death , atrial fibrillation , ventricular fibrillation , ablation
Key Clinical Message Implantable cardioverter‐defibrillator (ICD) is an effective therapy in patients known to be at high risk for sudden cardiac death (SCD). Nevertheless, ICD implantation is not indicated in transient or reversible causes of SCD. Wearable cardioverter‐defibrillator is increasingly used for SCD prevention in patients with a transient risk of ventricular arrhythmia.